Meeting
2023 ASCO Annual Meeting
Connecting Black families in Houston, Texas, to hereditary cancer genetic counseling, genetic testing, and cascade testing by using a simple cancer genetic risk assessment and telegenetics.
Authors
Darya Aleksandrovna Kizub
Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
Darya Aleksandrovna Kizub , Sreejesh Shanker , Sierra Green , Autumn Vara , Banu Arun
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Hereditary Cancer Syndromes
Clinical Trial Registration Number
NCT05694559
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr TPS10638)
DOI
10.1200/JCO.2023.41.16_suppl.TPS10638
Abstract #
TPS10638
Poster Bd #
270a
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic germline mutations prevalence in Saudi patients with pancreatic ductal adenocarcinoma.
First Author: Mohammed Ahmed Algarni
Poster
2019 Genitourinary Cancers Symposium
Genetic counseling processes and outcomes among prostate cancer patients (ProGen).
First Author: Donna Rachel Vatnick
Poster
2023 ASCO Annual Meeting
Comprehensive analysis of patients with cancer with a positive CHEK2 test: Are we getting closer to a genotype/phenotype correlation?
First Author: Ana Fragoso
Poster
2023 ASCO Annual Meeting
A randomized controlled trial evaluating pretest cancer genetics educational video or in-person genetic counseling.
First Author: Yanin Chavarri Guerra